Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Imagen
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== <vimeo>425812793</vimeo> We aim to benefit patients by revolutionising cancer research for pharma. Our unique innovative platform aims to identify the most effective cancer treatments, helping to deliver personalised, life-changing medicines. Every cancer is genetically unique, making it difficult for oncologists to predict which treatments to select & which to avoid. Imagen can test 1000's of individual tumours across a wide range of cancer drugs in-vitro, aiming to predict which are most likely to be effective. Imagen has fully developed its proprietary predictRx assay, enabling oncologists to refer patients to Imagen. This is creating a source of tumour samples to which industry does not have access, allowing Imagen to expand into the pharma sector by satisfying its unmet demand for patient-derived cancer models. In early-stage drug development, companies must use pre-clinical 'models' that closely resemble real patients, but few such models with patient-relevant data are available. This scarcity contributes to the high drug development failure rate (~95%), which Imagen is addressing by developing 1000's of patient-derived cancer models using its global access to patients. We require capital to scale our infrastructure with the aim of creating the world's leading Biobank of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)